Pranoprofen is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. It is grouped under the following drug class(es): Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Niflan and Elicapric. Its PubChem CID is 4888.
Pranoprofen
| CAS No | 52549-17-4 |
|---|---|
| Molecular Formula | C15H13NO3 |
| Molecular Weight | 255.27 g/mol |
| Synonyms | 2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pranoprofen is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. It is grouped under the following drug class(es): Non-Steroidal Anti-Inflammatory Drugs (NSAID).
The listed CAS number is 52549-17-4.
The listed molecular formula is C15H13NO3.
The listed molecular weight is 255.27 g/mol.
2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid.
The source lists Niflan and Elicapric.